Delivery Order V797D70166-36C25221F0088

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply POMALYST 2 MG CAPSULE 21S, a specialty pharmaceutical product, with a ceiling value of $36,863.70 and a performance period through April 9, 2024. This award is a task order under a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp to provide a comprehensive range of pharmaceuticals and...

This federal contract award is for the delivery of Pomalyst 3 mg capsules, a prescription medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $82,217.47, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. This is a delivery order awarded under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, valued at up to $999,999,999.00 and running through November 2026....

Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against their indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical. Valued at $12,084.50, this order is for the supply of 4562914807 POMALYST 4 MG CAPSULE 21S to support DLA medical facilities. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by December 18, 2023. No set-aside designation was applied to this award. As a...

This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,287.90, is for the delivery of POMALYST 2 MG CAPSULE 21S, a specialty pharmaceutical product. The contract has an ultimate completion date of April 1, 2024 and is a firm fixed-price arrangement. This award is not designated as a set-aside contract. AmerisourceBergen Drug...

This federal contract award, valued at $23,971.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of POMALYST 2 MG CAPSULE 21S, a specialty pharmaceutical product, with a period of performance through February 20, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...

This federal contract award, valued at $36,698.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of POMALYST 3 MG CAPSULE 21S, a pharmaceutical product, with a completion date of May 14, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up...

This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,236.98 fixed-price delivery order contract is for the supply of POMALYST 3 MG CAPSULE 21S, a specialty medication. The contract has an ultimate completion date of May 11, 2023 and was awarded on April 20, 2023. This contract is not designated as a set-aside and is part of a larger $999,999,999 Indefinite...

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,971.00, is for the delivery of Pomalyst 2 mg capsules to support military healthcare programs. It is a firm fixed-price, delivery order contract that runs through April 15, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...

This federal contract award, valued at $228,295.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pomalyst 1 mg capsules, a specialty medication, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a...

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $71,913.00, is for the supply of the prescription medication Pomalyst 4 mg capsules. It is a firm fixed-price contract with a performance period through May 6, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global...